Pharmaids Pharma Stock Price Analysis and Quick Research Report. Is Pharmaids Pharma an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Pharmaids Pharma. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Pharmaids Pharma has a PE ratio of -21.4353595438387 which is low and comparatively undervalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Pharmaids Pharma has ROA of -9.6114% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Pharmaids Pharma has a Current ratio of 4.3126.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Pharmaids Pharma has a ROE of -10.6426%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Pharmaids Pharma has a Debt to Equity ratio of 0.1759 which means that the company has low proportion of debt in its capital.

• Sales growth: Pharmaids Pharma has reported revenue growth of 0% which is poor in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Pharmaids Pharma for the current financial year is -22912.2302158273%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Pharmaids Pharma is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Pharmaids Pharma is Rs -2.8411. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Pharmaids Pharma in Ticker for free. Also, one can get the intrinsic value of Pharmaids Pharma by using Valuation Calculators, which are available with a Finology ONE subscription. 

Pharmaids Pharma FAQs

Q1. What is Pharmaids Pharma share price today?
Ans: The current share price of Pharmaids Pharma is Rs 60.9.

Q2. What is the market capitalisation of Pharmaids Pharma?
Ans: Pharmaids Pharma has a market capitalisation of Rs 214.78097508 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Pharmaids Pharma?
Ans: The PE ratio of Pharmaids Pharma is -21.4353595438387 and the P/B ratio of Pharmaids Pharma is 3.61426477308471, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Pharmaids Pharma share?
Ans: The 52-week high share price of Pharmaids Pharma is Rs 87.46, and the 52-week low share price of Pharmaids Pharma is Rs 31.9.

Q5. Does Pharmaids Pharma pay dividends?
Ans: Currently, Pharmaids Pharma does not pay dividends. Dividend yield of Pharmaids Pharma is around 0%.

Q6. What are the face value and book value of Pharmaids Pharma shares?
Ans: The face value of Pharmaids Pharma shares is Rs 10, while the book value per share of Pharmaids Pharma is around Rs 16.8499. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Pharmaids Pharma?
Ans: Pharmaids Pharma has a total debt of Rs 12.5 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Pharmaids Pharma?
Ans: The ROE of Pharmaids Pharma is -10.6426% and ROCE of Pharmaids Pharma is -10.8662%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Pharmaids Pharma a good buy for the long term?
Ans: The Pharmaids Pharma long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Pharmaids Pharma undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Pharmaids Pharma appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Pharmaids Pharma’s financials?
Ans: You can review Pharmaids Pharma’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.